Therapeutics: Phosphoribosyl pyrophosphate synthetase 1 (PRPS1)

Cancer

INDICATION: Acute lymphoblastic leukemia (ALL)

In vitro studies suggest the purine synthesis inhibitor lometrexol could help treat thiopurine-resistant ALL.